Home | MyCME | All CME | Blog | Psychlopedia
​CME From PCC
​​​​​
Multimedia | CME From JCP | JCP Supplement | CME From PCC

CME From PCCDoes the capacity to consent vary between medical and psychiatric patients? Are tools needed to assess the patient’s decision-making capacity, or can the provider’s assessment be relied upon? Review the results of a study that sought answers to these questions in this CME journal activity. [top]

PCC CME Activities

Who Has the Ability to Consent?

La Vonne Ann Downey and Les Zun

Psychiatric Prodrome in Anti-NMDAR–Associated Encephalopathy: Clinical and Pathophysiologic Considerations

Anh-Vu Nguyen, Keith A. Young, James A. Bourgeois

Organic Psychosis Causing Secondary Schizophrenia in One-Fourth of a Cohort of 200 Patients Previously Diagnosed With Primary Schizophrenia

João Gama Marques

Glucagon-Like Peptide Analogs Are Superior for Diabetes and Weight Control in Patients on Antipsychotic Medications: A Retrospective Cohort Study

Lauren T. Perlis; J. Steven Lamberti; and Susanne U. Miedlich

Hypertensive Urgency and Emergency in Alcohol Withdrawal: A Literature Review

Ermal Bojdani, Anderson Chen, Tina Zhang, Nida Naqvi, Dil Tahera

No MMSE for You! A Case of an “Uncooperative” Patient With Early-Onset Dementia

Po-Heng Tsai, Gurmehr Kaur, Ganesh Gopalakrishna

Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—HDC/DFMC Bridge Project, Phase 1: Group Concept Mapping

Keri Hager; Margarette Kading; Carolyn O’Donnell; Ann Yapel; Danielle MacDonald; Jennifer Nelson Albee; Cynthia Nash; Colleen Renier; Katherine Dean; and Mark Schneiderhan

Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review

Ivan Netto, Vivek H. Phutane, and Bipin Ravindran

Posttraumatic Stress Disorder Symptoms, Functioning, and Suicidal Ideation in US Military Veterans: A Symptomics Approach

Lorig K. Kachadourian, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

Psychotropic Medication Monitoring: A Review

Matthew A. Schreiber, Stephanie C. Armstrong, and Jesse D. Markman

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder

Mohan Gautam and Deepak Prabhakar

Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility

Gloria Martz, William Tankersley, Hema Madhuri Mekala, and Huda Motiwala, MD